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Abstract: Traditionally eukaryotic genes are considered independently expressed under the control of their promoters and 
cis-regulatory domains. However, recent studies in worms, flies, mice and humans have shown that genes co-habiting a 
chromatin domain or “genomic neighborhood” are frequently co-expressed. Often these co-expressed genes neither con-
stitute part of an operon nor function within the same biological pathway. The mechanisms underlying the partitioning of 
the genome into transcriptional genomic neighborhoods are poorly defined. However, cross-species analyses find that the 
linkage among the co-expressed genes of these clusters is significantly conserved and that the expression patterns of genes 
within clusters have coevolved with the clusters. Such selection could be mediated by chromatin interactions with the nu-
clear matrix and long-range remodeling of chromatin structure. In the context of human disease, we propose that dysregu-
lation of gene expression across genomic neighborhoods will cause highly pleiotropic diseases. Candidate genomic neigh-
borhood diseases include the nuclear laminopathies, chromosomal translocations and genomic instability disorders, im-
printing disorders of errant insulator function, syndromes from impaired cohesin complex assembly, as well as diseases of 
global covalent histone modifications and DNA methylation. The alteration of transcriptional genomic neighborhoods 
provides an exciting and novel model for studying epigenetic alterations as quantitative traits in complex common human 
diseases. 
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INTRODUCTION 
  Gene expression is epigenetically regulated by DNA 
methylation, histone modifications, and chromatin remodel-
ing [1]. The covalent modification of DNA and histones al-
ters chromatin structure changing promoter accessibility to 
transcription factors. These DNA and histone modifications 
impose a level of transcriptional regulation in addition to the 
nuclear concentration and covalent modification of transcrip-
tion factors. Therefore, in the context of a gene promoter, 
these DNA and histone modifications influence the binding 
of transcription factors and the regulation of gene expression 
[1].  
  Except for a few clusters of functionally related genes 
such as the rRNA, histone, Hox, and globin genes that are 
frequently co-regulated, the general perception has been that 
functionally unrelated genes are not co-regulated but are 
independently expressed under the control of their promoters 
and associated regulatory domains. However, in contrast to 
this perception, several recent studies in yeast, worms, flies, 
mice and humans have shown that genes co-habiting a 
chromatin domain or “genomic neighborhood” are fre-
quently co-expressed [2-10]. Often these co-expressed genes 
do not function within the same biological pathway [10]. 
  The mechanisms for partitioning the genome into clusters 
of co-expressed genes are poorly understood. However, the  
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conservation of clustering across species suggests that this 
organization did not arise randomly but by selection and 
therefore perturbation of this organization could be deleteri-
ous. We review the evidence for co-expressed gene clusters, 
or genomic neighborhoods, discuss possible regulators of 
these clusters, and review a group of human disorders poten-
tially disrupting genomic neighborhoods.  
GENOMIC NEIGHBORHOODS 
  Microarray, Serial Analysis of Gene Expression (SAGE) 
and Expressed-Sequence Tag (EST) analyses of gene expres-
sion have shown that many genes are organized into co-
expressed clusters. Simplistically, these co-expressed gene 
clusters can be organized into three groups: 1) paralogous 
genes arising from gene duplications, 2) functionally related, 
non-duplicated genes, and 3) unrelated, non-duplicated genes 
that are co-expressed. Paralogous gene clusters contain genes 
that arose through tandem duplications resulting in genes 
that are often co-expressed as observed for duplicate gene 
clusters in C. elegans [5]. However, as illustrated by the 
clustered Hox genes, which are temporospatially co-regula- 
ted, not all clustered paralogous genes are necessarily co-
expressed [11]. Clusters of functionally related genes include 
genes within the same pathway, genes encoding interacting 
proteins, or genes that affect the same trait. Not all function-
ally related genes are clustered within or among species. For 
example, genes within the same metabolic pathway, as de-
fined by the Kyoto Encyclopedia of Genes and Genomes 
(KEGG) cluster in humans, whereas genes within the same 
Gene Ontology do not cluster in humans [12, 13]. Clusters of  
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co-expressed unrelated, non-duplicated genes can be subdi-
vided into those that are co-expressed at a fixed developmen-
tal time and/or location or into those that are co-expressed at 
all times and in all locations. For example, within the human 
genome, co-expression of housekeeping gene clusters has 
been found in addition to tissue-specific gene clustering of 
cartilage-expressed transcripts [14, 15].  
S. cerevisiae  
    Genomic clustering of co-expressed genes was first 
identified in studies of S. cerevisiae genes with cell-cycle 
dependent expression patterns [4]. About 25% of the genes 
expressed during the same phase of the cell cycle are ar-
ranged as pairs [16].  
C. elegans 
  Unlike most other eukaryotes, C. elegans has approxi-
mately 15 percent of its genes organized into operons, which 
are transcribed as polycistronic messages. These messages 
are subsequently processed into monocistronic mRNAs by 
trans-splicing [17]. Thus the genes within these operons are 
transcriptionally co-regulated. Additionally, tandem duplica-
tion of genes results in co-expression of many paralogues. 
Interestingly however, transcriptional co-expression is not 
limited to operons and tandem duplications because when 
the transcriptional data from such genes are excluded, the 
remaining genes are still transcriptionally clustered [5, 7, 9]. 
Also, some of this clustering reflects co-regulation of tissue-
specific genes such as those expressed during spermatogene-
sis and in larval muscle [7, 9]. These observations support 
the idea that genomic neighborhoods are structural features 
that are, at least in part, independent of its occupants. 
Drosophila 
 In  Drosophila melanogaster, about 20% of genes are 
arranged into clusters spanning 20 to 200 kb and containing 
10 to 30 genes each [10]. Spellman and Rubin found that 
although paralogues and genes encoding functionally related 
products cluster, the gene composition of many other clus-
ters is not defined by these identifiers [10].  In the transcrip-
tional co-expression of adjacent genes observed by Boutan-
aev et al., a third of testes-specific genes were expressed in 
clusters of two to six genes yet only about 16% of these clus-
ters contained two or more paralogues [2]. Therefore, gene 
duplications account for many two-gene clusters but are not 
characteristic of clusters containing three or more co-
expressed genes [2].  
Mouse 
  Profiling of murine testes-specific ESTs showed that the 
mouse genome contains clusters of genes that are specifi-
cally expressed in the testis [6]. As observed in C. elegans 
and  Drosophila, nonparalogous genes co-expressed in the 
testes were organized into large clusters on all mouse chro-
mosomes [6]. Similarly, the profiling of murine oocyte-
specific ESTs identified oocyte-specific clusters of co-
expressed genes adjacent to the telomeres of chromosomes 
9, 12, 14 and 19 [8]. Because oocyte-specific genes outside 
of these clusters were not biased toward a telomeric location, 
the authors suggested that the oocyte-specific telomeric clus-
ters were nonrandom [8]. Additionally they suggested that 
this organization facilitates silencing of oocyte-specific 
genes in non-ovarian tissues because murine telomeres were 
highly heterochromatic [8]. Therefore these oocyte-specific 
clusters may constitute genomic neighborhoods that are 
regulated and controlled in a tissue-specific manner by 
higher order genomic organization. 
Human 
  In humans, highly expressed genes cluster in large do-
mains called RIDGEs (Regions of IncreaseD Gene Expres-
sion) and, interestingly, 40-50% of these RIDGEs map to 
telomeres [3]. Caron et al. observed that chromosomes with 
high gene density contain an increased number of RIDGEs 
when compared to chromosomes with low gene density [3]. 
More specifically, RIDGEs themselves have high gene and 
short interspersed nuclear repetitive DNA element (SINE) 
density and high GC content [3, 18].  
  Examining human Serial Analysis of Gene Expression 
(SAGE) data from 14 different types of tissues, Lercher et al. 
identified co-expression clusters of highly expressed house-
keeping genes but not of tissue-specific genes [14]. Similar 
to RIDGEs, these clusters were highly correlated with re-
gions of high GC content [18, 19]. Based on these observa-
tions, they hypothesized that housekeeping genes would be 
clustered in open chromatin to facilitate transcription. Con-
sistent with this, they found that highly expressed gene clus-
ters associated cytogenetically with the lightest staining 
Giemsa bands, i.e., relaxed chromatin [19].  
  While mapping cartilage-expressed transcripts (CETs) in 
the human genome, Yager et al. was able to identify cluster-
ing of co-expressed non-housekeeping genes Moreover, it 
has recently been shown that human embryonic stem cells 
contain co-expression domains that are distinguishable from 
co-expression domains identified in the embryoid body [20]. 
These data suggest that not all clusters of co-expressed genes 
consist of housekeeping genes, but rather some clusters also 
constitute tissue-specific genes, or even differentiation-
specific genes.  
  Further refining the co-expression clusters within the 
human genome, Sémon and Duret found that ~65% of the 
human genes belong to co-expressed gene clusters and that 
the distribution of cluster size, as judged by the number of 
genes, is biased toward small clusters [21]. The clusters that 
they defined also were not limited to functionally related or 
housekeeping genes.  
  In summary, clustering of co-expressed genes occurs 
with each species and across species [12, 21-23]. Interest-
ingly, this is not only applicable to paralogues, functionally 
related genes, tissue-specific genes, or housekeeping genes 
but also apparently to unrelated genes. Studies in several 
species show that clusters of co-expressed genes fall within 
genomic regions containing low recombination rates, dem-
onstrate coevolution of gene expression with gene clustering, 
and conservation of clusters between species. These observa-
tions suggest that these co-expressed clusters are maintained 
by natural selection [24-26]. Therefore, if the assembly of 
co-expressed genes into clusters is nonrandom, then this or-
ganization must be highly regulated within the three-dimen- 
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that the loss of this organization would be deleterious to the 
organism.  
THREE-DIMENSIONAL NUCLEAR ORGANIZA-
TION AND GENE REGULATION 
  Although the mechanisms responsible for partitioning the 
genome into regions of co-expressed clusters are incom-
pletely defined, our current understanding of the three-
dimensional organization of the nucleus suggests possible 
candidate mechanisms. Factors contributing to the formation 
of genomic neighborhoods likely include chromosomal spa-
tial orientation, chromatin interaction with the nuclear lam-
ina, and the association of chromatin with subnuclear struc-
tures.  
 Oliver  et al. proposed three models for co-expression of 
non-paralogous genes: 1) the incidental expression model, 2) 
the chromatin domain model and 3) the three-dimensional 
space model [27]. The incidental expression model predicts 
that when a transcription factor binds a target gene, it also 
incidentally activates neighboring genes and that this inci-
dental co-expression of neighboring genes may have little 
biological relevance. The structural domain model proposes 
that the opening of an entire genomic neighborhood facili-
tates the binding of the transcriptional machinery to any gene 
within the neighborhood and that these neighborhoods would 
be demarcated and regulated by boundaries such as insulator 
complexes. Finally, according to the three-dimensional space 
model, a target gene is recruited to a subnuclear location 
such as a transcription factory and adjacent genes would also 
be exposed to the transcription machinery and therefore also 
transcribed [27]. Each of these non-exclusive models empha-
sizes a different aspect of nuclear architecture and thus pro-
vides a slightly different mechanistic view of the role for 
nuclear architecture in regulation of genomic neighborhoods. 
Nuclear Envelope  
  The lamins and associated proteins are the major compo-
nents of the nuclear lamina. These proteins maintain the in-
tegrity of the nuclear envelope [28], provide a structural at-
tachment point for chromatin [29], help define DNA replica-
tion sites [28, 30-32], localize nuclear bodies [33], and facili-
tate transcription [34-37]. Spann et al. showed that interfer-
ing with lamin organization inhibited RNA polymerase II 
activity and therefore suggested that the nuclear lamina is 
required for the assembly of basal transcription factors and 
RNA polymerase II [36]. A role for the nuclear lamina in 
gene expression is further substantiated by interaction of 
lamin-associated proteins with the transcriptional apparatus. 
For example, emerin, an inner nuclear envelope protein, not 
only binds lamins A and B but also interacts with the trans- 
cription factors GCL, Btf, Lmo7, BAF, and YT521-B [34, 
37-41]. The roles of the nuclear lamina in defining regions of 
transcriptional co-expression have not been reported. How-
ever, as described below, the pleiotropic disorders associated 
with mutations of the nuclear lamina suggest that it has both 
global and tissue-specific effects on gene expression.  
Nuclear Genomic Organization 
  Rabl first proposed a territorial organization of interphase 
chromosomes in 1885 [42]. Interphase nuclei have regions of 
high density (heterochromatin), regions of lower density 
(euchromatin), and regions of lowest density (nucleoli) [43]. 
However, the DNA from the various chromosomes is not 
randomly intertwined, rather chromosomes occupy non-
overlapping territories of irregular shape [44-48]. There are 
two existing models for the distribution of chromosome terri-
tories [49]. One model suggests that gene-dense chromo-
somes are located more internally than gene-poor ones. Al-
though not consistently observed [50], this arrangement has 
been frequently reported for mammalian and chicken cells 
[46, 51, 52] as well as for homologous chromosomes in 
higher primates [53] and syntenic chromosomes in humans 
and mice [54, 55]. The other model proposes that chromo-
somal territories are organized by gene function. For exam-
ple, chromosomal organization arises from interactions be-
tween chromosome territories or domains required for DNA 
repair and homologous recombination [49, 56].  
  Development-specific and cell cycle-specific spatial 
alignment of homologous chromosome segments occurs in 
Drosophila [57-59] and for mammalian chromosomes in a 
variety of cells [60, 61]. Interestingly, the positioning of in-
terphase chromosomes is largely inherited from mother to 
daughter nuclei in mammals suggesting that this may be a 
high order epigenetic regulatory mechanism [62-66].  
Subnuclear Structures and the Interchromosomal Do-
mains 
  Chromatin from separate territories minimally intermin-
gles [46, 67]. Electron microscopy and polymerization of 
probes such as vimentin clearly define an interchromosomal 
domain or space between chromosomal territiories [68-72]. 
Nuclear bodies, such as Cajal and PML bodies, speckles, and 
specific nascent RNA accumulations lie in the interchromo-
somal domains along the surface of chromosome territories 
and are excluded from the chromosome territories [69, 72-
75]. Genes are generally distributed along the periphery of 
chromosome territories and invaginating channels where 
they can loop out into interchromosomal domains upon the 
induction of expression [54, 55, 76-80]. Thus, transcription 
may predominate along the periphery of a chromosome terri-
tory since this would allow access for transcription factors 
and facilitate processing and transport of mRNA [46, 71, 72, 
77]. Moreover, these findings suggest that the topology of 
genes relative to the interchromosomal domain compartment 
might provide a framework for the clustering of co-expressed 
genes and contribute to the overall regulation of gene ex-
pression [46, 67, 71, 72, 77, 81, 82].  
Boundary Elements 
  Observations from yeast, Drosophila, chicken, mouse 
and human studies show that insulators compartmentalize 
the genome into separate regions of gene expression through 
interactions with DNA, the nuclear matrix, and other protein 
components [83-85]. Through these interactions, insulator 
complexes are proposed to facilitate the formation of higher 
order genomic structures that can be independently regulated 
and are defined by two activities: 1) they can inhibit the 
spread of heterochromatin, and/or 2) they can block a tran-
scriptional enhancer from activating a promoter when lo-
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  One of the best-studied insulators is the gypsy element 
found in the Drosophila gypsy retrotransposon. Proteins that 
directly or indirectly bind the gypsy insulator include sup-
pressor of hairy wing, modifier of mdg4, Centrosomal pro-
tein 190 kD, Trithorax-like, and components of the nuclear 
matrix [86- 89]. Modulation of the interaction between these 
proteins and the gypsy insulator sequences defines higher 
order chromatin structures, such as chromatin loops, and the 
functionality of each gypsy sequence [86, 87, 89].  
  In vertebrates, our understanding of insulator function 
primarily comes from studies of imprinted genomic domains, 
such as the Beckwith Weideman region, and the beta-globin 
gene cluster [90, 91]. CCCTC-binding factor (CTCF), which 
binds the insulator sequences in these regions as well as 
many other sites, is the best-characterized mammalian insu-
lator-binding protein. The 5’ CHS4 insulator sequence, 
which is located upstream of the beta-globin cluster, has two 
separable functions: 1) it inhibits the adjacent heterochro-
matin from spreading into the beta-globin locus, and 2) it 
blocks enhancer-promoter interactions [92]. In addition to 
binding sequences such as CHS4, CTCF binds nucleophos-
min, a nucleolar protein, and components of the nuclear ma-
trix [93-95]. Binding of CTCF to the CHS4 and other insula-
tors is proposed to facilitate the formation of chromatin 
loops and tether these loops to subnuclear structures, such as 
the nucleolus and the nuclear matrix [95].  
  Another chromatin structural motif that is potentially 
involved in the establishment of genomic neighborhoods is 
the cohesin complex. Cohesin complexes were originally 
identified for their role in maintaining sister chromatid cohe-
sion prior to their separation during anaphase [96]. The Dro-
sophila protein Nipped-B loads the cohesin complex onto the 
chromosomes and is also required for facilitating enhancer-
promoter communication [97-99] and regulating gene ex-
pression [97]. This suggests that cohesin complexes may 
also be structural elements defining and regulating gene co-
expression domains and that impaired or errant localization 
of cohesin complexes could affect RNA transcription across 
large genomic regions.  
  In summary, the three-dimensional structure of the nu-
cleus provides a context for understanding and elucidating 
transcriptional genomic neighborhoods and an experimental 
basis for understanding the incidental expression, chromatin 
domain and three-dimensional space models for clustering of 
co-expressed genes. The intricate architecture of the nucleus 
and the nonrandomness of genomic neighborhoods suggest 
that perturbations at many different levels could cause dys-
regulation of genomic neighborhoods. This would result in 
altered spatial localization of chromatin within the nucleus 
and ultimately predispose to diseases that could affect multi-
ple organ systems.  
DEREGULATION OF GENOMIC ORGANIZATION 
AND DISEASE 
  To date, most epigenetic research in human disease has 
focused on the histone and DNA modifications occurring at 
discrete gene loci. Increasingly, however, genome-wide al-
terations are being identified in human cancers and in rare 
Mendelian disorders. These disorders affect gene expression 
through disruption of higher order genomic organization, and 
we review a set of diseases illustrating this. We have 
grouped the disorders in a hierarchy extending from three-
dimensional intramolecular positioning of chromosomes to 
those resulting in molecular alterations of DNA across ge-
nomic neighborhoods. 
Chromosomal Rearrangements: Disorders of Chromatin 
Localization? 
  As reviewed above, several studies have suggested that 
there are nuclear territories specific for each chromosome 
within a given cell type [49, 100-104]. Additionally, studies 
have shown that there are specific transcriptional regions or 
neighborhoods within the nucleus [46, 105]. These two ob-
servations suggest that reciprocal translocation of chromo-
somal segments would alter gene expression by placing the 
gene in a different transcriptional environment within the 
nucleus. Thus, the pathology arising from the translocations 
is not limited to disrupting genes, separating genes from cis 
regulatory elements, or placing genes within a new cis chro-
matin environment [106-109] but could also arise by chang-
ing the position of a gene or group of genes relative to the 
interchromosomal domain compartment and associated tran-
scription factors. To date, this model has not been exten-
sively investigated in somatic or germline human diseases 
associated with chromosomal rearrangements and genome 
instability. 
Nuclear Envelopathies: Disorders of Nuclear Envelop 
Integrity and Maintenance of Chromosomal and Inter-
chromosomal Domains? 
  The lamins and associated proteins constitute major 
components of the nuclear lamina and are involved in main-
taining the integrity of the nuclear envelope [28], providing a 
structural attachment point for chromatin [29], defining 
DNA replication sites [28, 30-32], localizing nuclear bodies 
[33], and mediating transcription [34-37]. Based on these 
identified functions, disruption of the nuclear matrix would 
impair the ability of chromatin to attach to the nuclear lam-
ina and thereby hinder the ability of a cell to define and to 
maintain the domains necessary for appropriate gene expres-
sion and genomic stability. Mutations of nuclear lamina pro-
teins have been identified in many different diseases includ-
ing Emery-Dreifuss muscular dystrophy (OMIM #310300, 
#181350, #604929), dilated cardiomyopathy (OMIM 
#115200), Charcot-Marie-Tooth disease (OMIM #605588), 
mandibuloacral dysplasia (OMIM #248370, #608612), Dun-
nigan-type familial partial lipodystrophy (OMIM #151660), 
Hutchinson-Gilford progeria (OMIM #176670), atypical 
Werner syndrome (OMIM #277700), Pelger-Huët anomaly 
(OMIM #169400), Greenberg skeletal dysplasia (OMIM 
#215140), restrictive dermopathy (OMIM #275210), melor-
heostosis (OMIM #155950), Buschke-Ollendorff syndrome 
(OMIM #166700), and lipoatrophy with diabetes, hepatic 
steatosis, hypertrophic cardiomyopathy, and leukomelano-
dermic papules (OMIM #608056) [110].  
  Given the role the nuclear lamina plays in regulating 
transcription [34-37], we propose that disruption of the nu-
clear lamina might affect transcription by altering the nuclear 
organization defining genomic neighborhoods. Consistent 
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loacral dysplasia and Emery-Dreifuss muscular dystrophy 
were consistent with a deregulation of gene expression at 
multiple loci [111-113]. Therefore, superimposed on the 
impaired DNA repair and nuclear envelope stability, altera-
tions in transcription help explain the pleiotropy, variable 
penetrance, and variable expressivity of diseases associated 
with mutant lamina proteins.  
Schimke Immuno-Osseous Dysplasia: a Disorder of Ge-
nomic Neighborhood Establishment and Maintenance? 
 Mutations in SMARCAL1 (SWI/SNF-related, matrix-asso- 
ciated, actin-dependent regulator of chromatin, subfamily
 A-
like 1) cause Schimke immuno-osseous dysplasia (SIOD; 
OMIM 242900). SIOD is an autosomal recessive disorder of 
T-cell immunodeficiency, spondyloepiphyseal dysplasia, 
renal failure, hypothyroidism, episodic cerebral ischemia, 
and bone marrow failure. Both clinical and cell culture stud-
ies suggest that functional SMARCAL1 protein is required 
for the proliferation of many of the affected tissues [114-
116]. Consistent with its role as an annealing DNA helicase 
[117], the SMARCAL1 protein binds nucleosomes and has 
DNA-dependent, RNA-independent, ATPase activity [118, 
119]. The SMARCAL1 protein is predominantly localized to 
the open chromatin and loss of functional SMARCAL1 ap-
parently causes cell autonomous disease by altering chroma-
tin helical torsion [117, 120]. In SMARCAL1 mutant tissues, 
transcription is altered across entire genomic neighborhoods 
suggesting that SMARCAL1 is necessary either for the es-
tablishment or maintenance of transcriptional genomic 
neighborhoods [Boerkoel, CF, and co-workers, unpublished 
results].  
Cornelia de Lange Syndrome: A Disorder of Cohesin-
Regulated Transcription? 
 Mutations  in  NIPBL (Nipped-B-Like) results in Cornelia 
de Lange syndrome (CDLS: OMIM 122470). CDLS is an 
autosomal dominant multisystem disease characterized by 
distinctive facial features, growth retardation, hirsutism, up-
per limb reduction defects, cognitive impairment, and behav-
ioral abnormalities as well as other congenital malforma-
tions. In Saccharomyces cerevisiae, S. pombe and Xenopus, 
the NIPBL homologues (Scc2, Mis4 and Xscc2), known col-
lectively as adherins, load the cohesin protein complex onto 
chromosomes [121-125] and are required for sister chro-
matid cohesion. As described above, the Drosophila NIPBL 
homologue, Nipped-B, is not only required for sister chro-
matid cohesion but also for facilitating enhancer-promoter 
communication [97-99]. This latter observation suggests that 
the pathology of CDLS is not only due to precocious sister 
chromatid separation [126] but also due to aberrant transcrip-
tion. Since the cohesin complex binds approximately every 
10kb along the S. cerevisiae and S. pombe interphase chro-
mosome [127, 128], impaired or errant localization of cohe-
sin complexes have the potential to profoundly affect RNA 
transcription across large genomic regions. 
Roberts Syndrome: A Disorder of Cohesin-Regulated 
Transcription? 
 Mutations  in  ESCO2 (Establishment of Cohesion 2), 
which encodes an acetyltransferase, has been shown to cause 
Roberts syndrome (RBS: OMIM 268300) and SC phocome-
lia (OMIM 269000). RBS is an autosomal recessive disease 
characterized by hypomelia, growth deficiency, craniofacial 
anomalies, microcephaly, and mental deficiency. Severely 
affected infants may be stillborn or die shortly after birth. SC 
phocomelia, a milder disorder, has less limb reduction and 
includes flexion contractures, midfacial hemangioma, hy-
poplastic cartilage of ears and nose, scant silvery-blond hair, 
and cloudy corneae. In S. cerevisiae, S. pombe, Drosophila 
and H. sapiens, the ESCO2 homologues are required for sis-
ter chromatid cohesion [129-133] and are bound to chromo-
somes throughout the cell cycle [129, 130]. In addition to 
affecting mitotic progression and ploidy [134], we hypothe-
size that, like Cornelia de Lange syndrome, mutations of 
ESCO2 could give rise to aberrant transcription across large 
genomic regions and that this partially accounts for the pa-
thology of RBS and SC phocomelia.  
Rubenstein Taybi syndrome: A Local or Global Disorder 
of Histone Acetylation? 
 Mutations  in  CREBBP (cAMP-responsive element bind-
ing protein (CREB) binding protein) and in EP300 (e1a-
binding protein p300) cause Rubinstein Taybi syndrome 
(RTS: OMIM 180849). RTS is an autosomal dominant dis-
order of growth retardation, facial abnormalities, broad 
thumbs and toes, and mental retardation. As histone acety-
lases, CREBBP and EP300 promote the decondensation of 
chromatin and interact with many transcription factors to 
facilitate RNA transcription [135, 136]. More specifically, 
CREBBP-mediated histone acetylation plays a role in synap-
tic plasticity, long term memory and in ameliorating neu-
ronal degeneration [137-140]. This can partially explain the 
mental retardation seen in RTS, but the mechanisms by 
which decreased CREBBP dosage causes malformations 
remain obscure. If CREBBP and EP300 are generally in-
volved in facilitating the transcription of many or most 
genes, then decreased dosage of CREBBP and EP300 could 
globally impair the RNA transcription including that of ge-
nomic neighborhoods. 
ICF Syndrome: A Global Disorder of DNA Methylation? 
 Mutations in DNMT3B (DNA methyltransferase 3B) cause 
immunodeficiency-centromeric instability-facial anomalies 
syndrome (ICF: OMIM 242860). ICF syndrome is an auto-
somal recessive disorder of genomic methylation that mainly 
affects satellites 2 and 3 of constitutive heterochromatin, 
although centromeric alpha satellites [141], Alu sequences 
[142, 143], D4Z4 and NBL2 repeats [144], and certain im-
printed genes [145, 146] are also involved. In addition, the 
inactive X chromosome (Xi), which consists of facultative 
heterochromatin, is globally undermethylated although all 
sequences are not equally affected in all patients [143, 147]. 
Interestingly, Xi CpG island demethylation is not accompa-
nied by significant biallelic transcriptional reactivation [142, 
148], and consistent with this observation, histone modifica-
tions along the Xi are normal [149]. 
  Although there has not been an extensive analysis of the 
transcriptome of ICF patients, several considerations suggest 
that the pathology of ICF may be partially caused by large-
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locates chromosomal fragments to inappropriate chromo-
some territories; 2) loss of repetitive DNA methylation im-
pairs heterochromatin formation which is a key long-range 
transcriptional regulator; and 3) methylation of repetitive 
elements plays a key role in the regulation of chromatin 
boundary elements that modulate transcription.  
Rett Syndrome: A Disorder of Methylated DNA Recogni-
tion or of RNA Processing? 
 Mutations  in  MECP2 cause a spectrum of disorders in-
cluding Rett syndrome (OMIM 312750), neonatal-onset en-
cephalopathy, mental retardation, autism, and an Angelman-
like syndrome [150]. MECP2 binds methylated promoter 
sites and recruits the mSinA/Histone Deacetylase (HDAC) 1, 
2 corepressor complex [151]; this process mediates dynamic 
repression of gene expression [152, 153]. These data and 
transcriptome analyses suggest that the pathology associated 
with MECP2 mutations results from inappropriate gene ex-
pression [154, 155]. Consistent with this hypothesis, some 
patients with mutations in MECP2 exhibit histone H4 hy-
peracetylation [156] and dysregulation of alternative splicing 
of some genes [157]. Thus loss of functional MECP2 ap-
pears to mediate widespread alterations in gene expression at 
both the level of RNA transcription and mRNA processing. 
If MECP2 were necessary to facilitate the interaction of 
chromatin with the nuclear matrix, then such dysfunction 
could arise through altered proximity of genes to the inter-
chromosomal domains as well as through defects in the abil-
ity to form heterochromatin. 
Cancer: A Panoply of Disorders Affecting All Levels of 
Genomic Organization? 
  Cancerous tissue and tumor-derived cell lines exhibit 
errors at nearly all levels of nuclear organization including 
chromosomal aberrations [158, 159], altered nucleosome 
spacing [109], covalent histone modifications [160], and 
DNA methylation [161]. Besides the established roles in loss 
of heterozygosity for tumor suppressor genes and oncogene 
activation, we propose that chromosomal rearrangements 
might also play a role in cancer by altering the expression of 
genes across large domains by relocating them to a different 
chromosomal territory.  
  The cancer-associated ATP-dependent chromatin remod-
eling enzymes SMARCB1 (SWI/SNF-related, matrix-
associated, actin-dependent regulator of chromatin, subfam-
ily B, member 1) and BRG1 (brahma-related gene 1), and 
BRM (brahma) regulate gene expression by altering nu-
cleosome spacing [162-166]. Transcriptome analyses of tu-
mors with dysfunction of SMARCB1, BRG1, and BRM will 
clarify whether  transcriptional changes globally affect ge-
nomic neighborhoods or are targeted to specific genes.  
  Abnormalities of global and targeted histone acetylation 
occur in several human neoplasms. In acute promylelocytic 
leukemia, acute lymphocytic leukemia, and non-Hodgkins 
lymphoma, mutations of proteins that recruit HDACs to 
DNA errantly activate and target interacting HDACs [162]. 
In several human cancers, this results in a reduction of over-
all histone acetylation [167]. In addition, histone acetylases 
are deregulated in some human neoplasias; this dysregula-
tion plays a crucial role in tumor development and progres-
sion [168-171]. Underscoring the role of histone acetylation 
in cancer, HDAC inhibitors slow tumor cell proliferation and 
induce differentiation. These changes are associated with 
global affects on transcription [172, 173] and suggest that the 
tumor phenotype results from the altered expression of many 
genes.  
  Human tumor DNA is globally hypomethylated [174, 
175]. Malignant cells can have 20%–60% less genomic 5-
methyl-cytosine than normal counterpart cells [175]. How-
ever, genomic hypomethylation does not associate with 
overexpression of oncogenes. Rather three mechanisms have 
been invoked for the contribution of global DNA hypometh-
ylation to carcinogenesis: chromosomal instability, reacti- 
vation of transposable elements, and loss of imprinting [176-
179]. Each of these processes is involved in regulation of 
chromatin structure and likely in defining transcriptional 
genomic neighborhoods. Additionally, in contrast to the 
global hypomethylation, CpG islands in the promoter regions 
of many tumor suppressor genes undergo hypermethylation 
in cancer cells leading to gene silencing [180, 181], and the 
number of hypermethylated tumor suppressor genes in-
creases with the malignant potential [181-184]. Thus at the 
level of DNA methylation, the cancer phenotype appears to 
be a combination of global chromatin structural changes 
through overall DNA hypomethylation and of targeted gene 
inactivation through promoter hypermethylation. 
GENOMIC ORGANIZATION AND NATURAL SE-
LECTION  
  The correlation of perturbed genomic neighborhoods 
with disease suggests that they are functionally significant 
and not purely coincidental. This hypothesis is also sup-
ported by several lines of evidence that these clusters arose 
and are preserved by natural selection. First, co-expression 
clusters contain fewer chromosomal breakpoints between 
human and mouse than expected by chance [26]. Second, 
highly co-expressed clusters of genes are phylogenetically 
conserved between human and mouse and consist mainly of 
nonparalogous genes [185, 186]. Third, comparison of the 
human and chicken genomes shows that there is more link-
age retention among genes within clusters than outside of 
clusters [21]. Fourth, analysis of coexpression of neighbor-
ing genes within the mouse and human genomes suggests 
that there is coevolution of the pattern of expression in 
neighboring genes [21]. Fifth, genes within conserved re-
gions of synteny between Drosophila melanogaster and 
Drosophila pseudoobscura have highly correlated expres-
sion patterns [187]. 
CONCLUSIONS 
  Advances in our understanding of gene expression and 
distribution in the genome make the supposition of random 
gene order in eukaryotes increasingly untenable. Recent ad-
vances in nuclear biology have not only initiated novel views 
of the role of genomic organization in gene expression regu-
lation but also new insights into the cause of disease.  
  The nonrandom organization of the genome into a series 
of chromosomal blocks that are transcriptionally regulated 
provides possible insight into some recent unexplained ob-
servations during development. For example, during differ-70    Current Genomics, 2009, Vol. 10, No. 1  Elizondo et al. 
entiation of hematopoietic stem cells, particular chromoso-
mal regions are inactivated [188], and during differentiation 
of non-neuronal tissues, specific chromosomal intervals are 
transcriptionally down-regulated [189].  
  According to this model of genomic organization, the 
pathophysiology underlying many diseases could arise as a 
result of alterations in genomic organization causing quanti-
tative transcriptional disturbances. The cumulative effect of 
these transcriptional disturbances or the confluence of aber-
rant transcription of several genes would then sufficiently 
perturb homeostasis to predispose to or cause disease. Thus, 
for the rare Mendelian disorders considered above, the 
chromosomal aberration or mutant protein could effect the 
disease phenotype by causing quantitative changes in gene 
transcription through altering the nuclear localization or 
structure of large chromatin domains. The variable expres-
sivity of many of these disorders reflects the quantitative 
differences in transcription, and the phenotypic features can 
be considered quantitative traits. 
  Considering the features of these rare Mendelian disor-
ders as quantitative traits provides a model for the variable 
expressivity and pleiotropism; characteristics which cannot 
be explained simply by dysregulation of a single pathway or 
gene interaction network. It also explains why segregation of 
gene mutations for these diseases frequently predispose to 
rather than cause disease and why many features of these 
diseases have genocopies. Lastly, since genomic neighbor-
hoods are likely regulated by both genetic and epigenetic 
mechanisms, this model integrates both in the causation of 
human diseases.  
  Viewing co-expression of clustered genes as a quantita-
tive trait also provides an explanation of why genomic 
neighborhoods would be a substrate for and not only a prod-
uct of natural selection. In contrast to strong single gene mu-
tations that result in dramatic changes in fitness, alterations 
in expression of genes, and likely gene clusters, allow grad-
ual and persistent selection of offspring that are more fit than 
their parents [190]. Moreover, since mRNA levels for many 
genes are heritable [191], gene expression and co-expressed 
gene clusters could be the subject of selection over many 
generations. 
  In this context, the features of these rare Mendelian dis-
orders provide a novel method for modeling and studying 
quantitative traits and multifactorial disorders. Such disor-
ders include mental retardation, diabetes, hypertension, athe-
rosclerosis, vascular cognitive impairment, and Metabolic 
Syndrome (type 2 diabetes, cardiovascular disease, and hy-
pertension). Schimke immuno-osseous dysplasia (SIOD) 
nicely illustrates this for atherosclerosis and vascular cogni-
tive impairment. Approximately half of SIOD patients de-
velop vascular cognitive impairment secondary to athero-
sclerosis. Since mutations of SMARCAL1 alter transcription 
across chromatin domains containing many genes with al-
tered transcription in atherosclerotic plaques, we hypothesize 
that the confluence of these multiple transcriptional changes 
predisposes to atherosclerosis. However, the degree of pre-
disposition is dependent on the level of transcriptional altera-
tion, and the development of atherosclerosis results from the 
interaction of these transcriptional changes with environ-
mental, genetic, and epigenetic factors. Therefore as a model 
for generic atherosclerosis, the regions of altered transcrip-
tion in SIOD are quantitative trait loci for atherosclerosis. 
Intersection of these loci with genetically identified disease 
loci further delineate the genes and pathways contributing 
not only to rare Mendelian disorders but also gives insight 
into the pathomechanism of complex diseases.  
FUTURE DIRECTIONS 
  Defining better the selective pressure for and on genomic 
neighborhoods and determining whether transcriptional al-
terations of these are a common cause of complex disorders 
requires further testing. These future studies will provide an 
exciting opportunity to define the heritable epigenetic varia-
tion contributing to complex diseases and address many of 
the questions regarding the contribution of epigenetic varia-
tion to quantitative traits. Additionally, these studies will 
allow investigators to clarify whether the increasing inci-
dences of diseases such as asthma, Metabolic Syndrome, and 
some neoplasias are due in part from increasing environ-
mental influences on epigenetic traits. Answering these ques-
tions is essential for defining the contribution of genomic 
organization in human disease. 
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